New dissolvable mesh for breast reconstruction under study

NCT ID NCT06511167

Recruiting now Symptom relief Sponsor: AWOgyn Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 135 women who have had breast reconstruction after mastectomy using a special dissolvable mesh called TIGR® Matrix. The goal is to see how the mesh affects their quality of life over three years. Participants will fill out a questionnaire about their symptoms and daily activities. The study is observational, meaning it just watches what happens without changing treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TIGR® Matrix (bioresorbable surgical mesh)
What this could lead to: If successful, this could confirm that the TIGR® Matrix is a safe and effective option for breast reconstruction, improving patient quality of life.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. Complications like infection or mesh issues are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer precancerous condition

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMPLANT BASED BREAST RECONSTRUCTION

Contacts and locations

Locations

Agaplesion Markus Krankenhaus Frankfurt
RECRUITING

Frankfurt am Main, Hesse, 60431, Germany
Evangelisches Krankenhaus Wesel
RECRUITING

Wesel, North Rhine-Westphalia, 46485, Germany
GRN-Klinik Weinheim
ACTIVE_NOT_RECRUITING

Weinheim, Baden-Wurttemberg, 69469, Germany
Klinik und Poliklinik für Frauenheilkunde Technische Universität München
RECRUITING

München, Bavaria, 80337, Germany
Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH
RECRUITING

Halle, 06110, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.